A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008
In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer. Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019
In vitro comparison of output and particle size distribution of budesonide from metered-dose inhaler with three spacer devices during pediatric tidal breathingSource: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005
In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation. Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020
Bronchodilatation and systemic β2 -response measurement in asthmatic patients after using salbutamol comparing a metal and a plastic spacer Source: Eur Respir J 2001; 18: Suppl. 33, 99s Year: 2001
The in vitro fine particle dose with Symbicort Rapihaler pMDI is similar using either NebuChamber or AeroChamber Plus valved holding chamber spacer devices Source: Eur Respir J 2005; 26: Suppl. 49, 504s Year: 2005
In vitro evaluation of a new spacer for pMDI and nebulizers in mechanical ventilation Source: Annual Congress 2012 - Multidisciplinary critical care Year: 2012
Aerosol characterization of three corticosteroids in MDIs plus a new spacer device (Fluspacer®) vs MDIs alone Source: Eur Respir J 2001; 18: Suppl. 33, 101s Year: 2001
In vitro performance of a small non-electrostatic valved holding chamber made from metal with three different brands of pressurized metered dose inhalers Source: Eur Respir J 2006; 28: Suppl. 50, 712s Year: 2006
Lung targeting of flunisolide is enhanced when delivered as an extra fine HFA aerosol with a built-in spacer Source: Eur Respir J 2001; 18: Suppl. 33, 70s Year: 2001
Effect of the actuator orifice diameter on the biodisposition of a new budesonide CFC-free metered dose inhaler formulation Source: Eur Respir J 2001; 18: Suppl. 33, 102s Year: 2001
Metered dose inhaler with spacer versus nebulizer in children with acute bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 429s Year: 2002
Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations Source: Eur Respir J 2005; 26: Suppl. 49, 340s Year: 2005
In vitro testing of an improved collapsible valved holding chamber (CHC) with a pressurized metered-dose inhaler delivered bronchodilator, simulating an adult mechanically ventilated patient Source: Annual Congress 2010 - Treatment options for asthma Year: 2010
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Assessment of relative potency of salbutamol administered via a metered-dose inhaler plus spacer or via a dry-powder inhaler in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 209s Year: 2006
Comparison of aerosol delivery from two inhaler technique-guidance devices. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
Efficacy and safety of salbutamol delivered via a novel multidose dry powder inhaler in comparison with two conventional dry powder inhalers and a pMDI in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 50s Year: 2001
Inhaler treatment options in COPD Source: Eur Respir Rev 2005; 14: 102-108 Year: 2005